Related Experiment Video
Updated: May 6, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.9K
Transparency in evidence evaluation and formulary decision-making: from conceptual development to real-world
P & T : a Peer-Reviewed Journal for Formulary Management
|November 14, 2013
Summary
A structured approach to evidence evaluation for formulary decision-making was developed. While intended to improve clarity and consistency, real-world testing revealed limitations, indicating a need for further refinement.
Area of Science:
- Health Services Research
- Pharmaceutical Policy
- Evidence-Based Medicine
Background:
- Formulary decision-making relies on evidence evaluation, impacting patients, payers, and providers.
- Current processes may lack clarity, consistency, and transparency.
Purpose of the Study:
- To develop and test a structured evidence-evaluation tool for formulary decision-making.
- To enhance clarity, consistency, and transparency in the formulary process.
Main Methods:
- An expert panel identified key constructs and developed an evidence-assessment tool.
- The tool underwent external validation via a large survey of decision-makers.
- Pilot-testing was conducted in a real-world Pharmacy and Therapeutics (P&T) committee setting.
Main Results:
- Survey data suggested a structured approach could improve clarity, consistency, and transparency.
- Pilot-testing in a P&T committee highlighted limitations of the structured tool in practice.
Conclusions:
- A structured approach to formulary decision-making shows potential benefits but was not fully realized in a real-world setting.
- Further development is needed to create an effective method for improving clarity, consistency, and transparency.
More Related Videos
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
303
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
303
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
370
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
370